Merck & Co. Inc. buy Barclays PLC
Start price
23.01.24
/
50%
€108.20
Target price
23.01.25
€124.16
Performance (%)
-14.23%
End price
24.01.25
€92.80
Summary
This prediction ended on 24.01.25 with a price of €92.80. The price of Merck & Co. Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -14.23%. Barclays_PLC has a follow-up prediction for Merck & Co. Inc. where he still thinks Merck & Co. Inc. is a Buy. A total of €2.89 was paid as dividends for this prediction. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | 3.614% | 3.614% | 25.243% |
| iShares Core DAX® | -1,66 % | -10,87 % | -0,72 % |
| iShares Nasdaq 100 | -3,77 % | -5,15 % | 13,41 % |
| iShares Nikkei 225® | -2,80 % | -11,30 % | 25,46 % |
| iShares S&P 500 | -2,30 % | -4,80 % | 8,94 % |
Comments by Barclays_PLC for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target raised by analysts at Barclays PLC from $130.00 to $135.00. They now have an "overweight" rating on the stock.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for Merck & Co. Inc.
Stopped prediction by Barclays_PLC for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€98.90
07.10.24
07.10.24
€127.58
07.10.25
07.10.25
-23.46%
08.10.25
08.10.25
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€104.60
31.07.24
31.07.24
€131.14
31.07.25
31.07.25
-34.80%
01.08.25
01.08.25
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€116.60
02.02.24
02.02.24
€134.11
02.02.25
02.02.25
-18.18%
03.02.25
03.02.25